Fiona H. Marshall
President, Biomedical ResearchNovartis
PharmaceuticalsView Profile →EVP, International · AstraZeneca
Iskra Reic is AstraZeneca’s executive vice president for International. Her career includes European commercial leadership and the creation of its Vaccines & Immune Therapies business before taking the wider International portfolio.
Last reviewed: Nov 16, 2026
Iskra Reic is AstraZeneca’s executive vice president for International. Her career includes European commercial leadership and the creation of its Vaccines & Immune Therapies business before taking the wider International portfolio.
Reic joined AstraZeneca in 2001 and held leadership positions across Central and Eastern Europe, Eurasia, the Middle East and Africa. Her education combines dental medicine in Zagreb with postgraduate business and leadership qualifications from IEDC-Bled.
In 2017 she became executive vice president for Europe and Canada and joined the company’s Senior Executive Team. She later launched the Vaccines & Immune Therapies unit and led it from 2021.
That business combined early- and late-stage development with commercial operations, medical affairs, partnerships and acquisitions. Its portfolio included COVID-19 and RSV vaccines and monoclonal antibodies.
In December 2024 Reic became executive vice president for International. The region encompasses China, other Asian and Eurasian markets, the Middle East and Africa, Latin America, Australia and New Zealand. Her additional appointments include the board of myTomorrows and the steering committee of the Partnership for Health System Sustainability and Resilience.
Ph.D. — IEDC-Bled School of Management — Strategy and Leadership.
International Executive MBA — IEDC-Bled School of Management — Business and Leadership.
Doctor of Dental Medicine — Medical University of Zagreb.